475 reports of this reaction
4.0% of all PHENTERMINE HYDROCHLORIDE reports
#2 most reported adverse reaction
NAUSEA is the #2 most commonly reported adverse reaction for PHENTERMINE HYDROCHLORIDE, manufactured by Aurolife Pharma, LLC. There are 475 FDA adverse event reports linking PHENTERMINE HYDROCHLORIDE to NAUSEA. This represents approximately 4.0% of all 12,013 adverse event reports for this drug.
Patients taking PHENTERMINE HYDROCHLORIDE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among PHENTERMINE HYDROCHLORIDE users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for PHENTERMINE HYDROCHLORIDE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 475 FDA reports for PHENTERMINE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 4.0% of all adverse event reports for PHENTERMINE HYDROCHLORIDE, making it one of the most commonly reported side effect.
If you experience nausea while taking PHENTERMINE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.